Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06343610
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-03-26
Brief Title:
The Effect of 8-week Dietary Intake of Novel Food Supplement on Minimal Erythema Dose
Sponsor:
VIST - Faculty of Applied Sciences
Organization:
VIST - Faculty of Applied Sciences
Study Overview
Official Title:
The Effect of 8-week Dietary Intake of Novel Food Supplement on Minimal Erythema Dose Randomised Double Blind Placebo-controlled Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIST-TO-UV
Brief Summary:
This is a double-blind randomized placebo-controlled interventional study of the effect of multiple-dose dietary intake on minimal erythema dose and other skin parameters
Detailed Description:
This is a double-blind randomized placebo-controlled interventional study of the effect of multiple-dose dietary intake on minimal erythema dose and other skin parameters
The study will be performed on 54 adults between the ages 21 and 65 years and will include daily dietary supplementation over 8-weeks period
Participants will be randomly assigned in one of two groups 27 in each One group test group will receive investigational product a syrup containing red orange extract Calaguala extract and vitamins A C D E and the other placebo syrup Participants will continuously receive placebo or investigational product for 8 weeks in order to determine multiple-dose effects
The study will be performed on 54 adults between the ages 21 and 65 years and will include daily dietary supplementation over 8-weeks period
Participants will be randomly assigned in one of two groups 27 in each One group test group will receive investigational product a syrup containing red orange extract Calaguala extract and vitamins A C D E and the other placebo syrup Participants will continuously receive placebo or investigational product for 8 weeks in order to determine multiple-dose effects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None